eye-light®
eye-light® is Espansione Group's flagship clinical platform — a modular, software-driven device designed to support clinicians in managing both anterior and posterior segment conditions within a single integrated system.
Overview
eye-light® brings together Espansione's two core technologies:
- LM™ LLLT (Red, Blue, and Yellow photobiomodulation)
- OPE™ IPL (software-controlled Intense Pulsed Light)
This combination enables non-invasive, light-based treatments across a wide range of ophthalmic conditions, from dry eye to early-stage AMD.
Modular Architecture
The latest generation of eye-light® features a modular, software-driven architecture built specifically for ophthalmic clinical environments:
- Up to nine treatment protocols for anterior and posterior care
- Protocols are expandable at any time without replacing the device
- Clinical applications can grow with the practice over time
- Designed for seamless integration into ophthalmic workflows
Certified Applications
| Condition Area | Technology Used |
|---|---|
| Dry Eye Disease (DED) / MGD | LM™ LLLT + OPE™ IPL |
| Blepharitis, Demodex, Chalazion | LM™ LLLT |
| Sjögren's Syndrome | LM™ LLLT |
| Pre/Post Cataract & Refractive Surgery | LM™ LLLT |
| Dry AMD (AREDS 2–3) | LM™ LLLT |
Regulatory Status
- CE marked as a Class IIA medical device (MDR)
- CE (MDR) Mark recently extended to cover dry AMD and expanded anterior segment pathologies
- Recognized in the TFOS DEWS III Management and Therapy Report
Not all solutions and use cases are available in all countries. Please contact Espansione Group for country-specific availability.